Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD.
Melike Kevser GulElif Funda SenerMuge Gulcihan OnalEsra DemirciPublished in: Journal of psychopharmacology (Oxford, England) (2021)
It was, however, found that the NET rs12708954 and rs3785143 genotypes affect the treatment response to ATX in our study; thus, further studies with a large population are needed to understand the effects of NET polymorphisms on treatment, side effects, and also the severity of ADHD.